BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34048369)

  • 1. The Janus Face of Coronavirus Disease 2019-Associated Coagulopathy.
    Stahl K; Seeliger B; Hofmaenner DA; Doebler M; Bode C; David S
    Crit Care Med; 2021 Oct; 49(10):e1049-e1050. PubMed ID: 34048369
    [No Abstract]   [Full Text] [Related]  

  • 2. Coagulopathy and thromboembolic events a pathogenic mechanism of COVID-19 associated with mortality: An updated review.
    Yousefi P; Soltani S; Siri G; Rezayat SA; Gholami A; Zafarani A; Razizadeh MH; Alborzi E; Mokhtary-Irani G; Abedi B; Karampoor S; Tabibzadeh A; Farahani A
    J Clin Lab Anal; 2023 Jun; 37(11-12):e24941. PubMed ID: 37431777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation and coagulopathy - an ominous duo in COVID19.
    Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
    Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19-associated coagulopathy.
    Franchini M; Marano G; Cruciani M; Mengoli C; Pati I; Masiello F; Veropalumbo E; Pupella S; Vaglio S; Liumbruno GM
    Diagnosis (Berl); 2020 Nov; 7(4):357-363. PubMed ID: 32683333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covid-19-induced coagulopathy and observed benefits with anticoagulation.
    Karimzadeh S; Dong V; Hassan OG; Raut A; Fouda A; Parrill A; Eaton K; Huy NT
    Transfus Apher Sci; 2020 Dec; 59(6):102906. PubMed ID: 32778522
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation.
    Salabei JK; Fishman TJ; Asnake ZT; Ali A; Iyer UG
    Heart Lung; 2021; 50(2):357-360. PubMed ID: 33524866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proposal for the management of COVID-19-induced coagulopathy in adults.
    Ignacio-Ibarra G; García-Lee MT; González-Ávila AI; García-Chávez J; Guzmán-Chores L; Cruz CL; Lugo-García Y; Juárez-Lara J; García-Vázquez M; Madera-Maldonado CE; Ramos-Peñafiel CO; Majluf-Cruz A
    Gac Med Mex; 2021; 157(2):201-206. PubMed ID: 34270538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronavirus Disease 2019-Associated Coagulopathy.
    Lippi G; Sanchis-Gomar F; Favaloro EJ; Lavie CJ; Henry BM
    Mayo Clin Proc; 2021 Jan; 96(1):203-217. PubMed ID: 33413819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focus on coronavirus disease 2019 associated coagulopathy.
    Yang XH; Li RR; Sun RH; Liu J; Chen DC
    Chin Med J (Engl); 2020 Sep; 133(18):2239-2241. PubMed ID: 32858589
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dealing with COVID-19-associated coagulopathy].
    Klok FA; den Exter PL; Huisman MV; Eikenboom J
    Ned Tijdschr Geneeskd; 2020 Apr; 164():. PubMed ID: 32395964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19-associated coagulopathy in children: A multicenter observational cohort study.
    Zabeida A; Winikoff R; Pelland-Marcotte MC; Charlebois J; Sabapathy C
    Pediatr Blood Cancer; 2023 Jan; 70(1):e30079. PubMed ID: 36326142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haematological manifestations of COVID-19: From cytopenia to coagulopathy.
    Agbuduwe C; Basu S
    Eur J Haematol; 2020 Nov; 105(5):540-546. PubMed ID: 32663356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation abnormalities & thromboprophylaxis in COVID-19.
    Jandial A; Gupta A; Malviya A; Agastam S; Kumar D
    Indian J Med Res; 2021 May&Jun; 153(5&6):606-618. PubMed ID: 34643567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Coagulopathy: From Pathogenesis to Treatment.
    Alnima T; Mulder MMG; van Bussel BCT; Ten Cate H
    Acta Haematol; 2022; 145(3):282-296. PubMed ID: 35499460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the COVID-19 coagulopathy spectrum.
    Thachil J; Agarwal S
    Anaesthesia; 2020 Nov; 75(11):1432-1436. PubMed ID: 32437586
    [No Abstract]   [Full Text] [Related]  

  • 16. [Coagulopathy and COVID-19. Recommendations for a changing reality].
    Riveros D; Maymó D; Laviano J; Fornillo FF; Fernández J; Benzadon R; Solimano J; Cacchione R; Riera L; Duarte P; Cazap N; Gotta D; García Altuve J; Valentini R; Dupont J
    Medicina (B Aires); 2020; 80(5):505-511. PubMed ID: 33048795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19-induced coagulopathy: Experience, achievements, prospects.
    Dubey L; Dorosh O; Dubey N; Doan S; Kozishkurt O; Duzenko O; Kozlova O; Ievtukh V; Ladny JR; Pruc M; Szarpak L; Pukach J
    Cardiol J; 2023; 30(3):453-461. PubMed ID: 36588310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination.
    Yamada S; Asakura H
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboembolic Disorder in COVID-19 Infection.
    Lee S; Gunderson J; Mushtaq R
    Curr Med Imaging; 2023; 19(14):1616-1627. PubMed ID: 36797601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines.
    Abdel-Bakky MS; Amin E; Ewees MG; Mahmoud NI; Mohammed HA; Altowayan WM; Abdellatif AAH
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.